CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC was delisted on the 23rd of June, 2023.
94 hedge funds and large institutions have $165M invested in CTI BioPharma Corp. (DE) Common Stock in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 16 reducing their positions, and 10 closing their positions.
567% more call options, than puts
Call options by funds: $1.57M | Put options by funds: $236K
144% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 16
109% more capital invested
Capital invested by funds: $78.9M → $165M (+$85.8M)
80% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 10
9% more funds holding
Funds holding: 86 → 94 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$45.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$24.3M |
| 3 |
SCM
Sio Capital Management
New York
|
+$7.07M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$4.27M |
| 5 |
DM
Deerfield Management
New York
|
+$2.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Teachers Advisors
New York
|
-$1.09M |
| 2 |
Millennium Management
New York
|
-$747K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$243K |
| 4 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
-$210K |
| 5 |
Barclays
London,
United Kingdom
|
-$136K |
CTIC Hedge Fund Activity: Q4 2015 in Review
94 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q4 2015, worth a combined $165M — up 109% from $78.9M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new CTIC positions and 10 closed out — a net gain of 8 holders — while 39 added to existing stakes and 16 trimmed.
The largest buyer was BVF Inc, adding an estimated $45.1M. The largest seller was Teachers Advisors, cutting an estimated $1.09M.
- 94 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q4 2015, up from 86 in Q3 2015.
- Funds reported $165M of CTI BioPharma Corp. (DE) Common Stock stock for Q4 2015, up 109% quarter-over-quarter.
- 18 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q4 2015 and 10 closed out, a net change of +8 holders.
- The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q4 2015 was BVF Inc, an estimated $45.1M added.
- The largest CTI BioPharma Corp. (DE) Common Stock seller in Q4 2015 was Teachers Advisors, an estimated $1.09M sold.
Based on aggregated 13F filings for Q4 2015.